Drug & supplement interaction

N,n-dmpea + Sorafenib

Sorafenib brand name: Nexavar.

No Known Interaction
The bottom line No known interaction

We found no known interaction between N,n-dmpea and Sorafenib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the label for Sorafenib states a food rule worth keeping to.

Know someone taking this? Share
Interaction report

N,n-dmpea and Sorafenib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Sorafenib and N,n-dmpea in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

N,n-dmpea safety at a glance

N,n-dmpea overall Use caution Human safety data are very limited, and stimulant-like effects are possible.
Pregnancy Avoid No safety data exist, so it should be avoided during pregnancy.
Breastfeeding Avoid No safety data exist, so it should be avoided while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Sorafenib and N,n-dmpea? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Sorafenib

Interactions in our licensed database are recorded against drug classes, not just single drug names. Sorafenib is filed under 4 classifications — including anticoagulant/antiplatelet drugs, glucuronidated drugs, cytochrome p450 3a4 (cyp3a4) substrates. N,n-dmpea has documented interactions with 1 drug class — the most serious being cytochrome p450 2d6 (cyp2d6) substrates (moderate) — and none of Sorafenib’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

N,n-dmpea Does Interact With Other Medications

N,n-dmpea has 193 moderate known drug interactions in our database — Sorafenib isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against N,n-dmpea

Covers the 2,830 medications we’ve checked against N,n-dmpea. Pick one to open its full report.

What to actually watch for

What Sorafenib’s Own FDA Label Lists

This is not an interaction — none of it involves N,n-dmpea. These are the most notable effects listed in the ADVERSE REACTIONS section of Sorafenib’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 4 of them are worth acting on rather than waiting out — marked below.

  • Raised blood pressure Worth acting on
  • Liver problems Worth acting on
  • Bleeding or bruising Worth acting on
  • A higher chance of infection Worth acting on
  • Weight loss
  • Reduced appetite mentioned in 7.0% of FDA reports for Sorafenib
  • Hair loss
  • Diarrhea mentioned in 14.3% of FDA reports for Sorafenib
  • Tiredness mentioned in 8.7% of FDA reports for Sorafenib
  • A skin rash mentioned in 7.1% of FDA reports for Sorafenib

Showing the 10 most notable of 11 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Sorafenib. Read the label on DailyMed › Where a percentage is shown, it is the share of 20,576 voluntary FDA FAERS reports for Sorafenib that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. N,n-dmpea’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no N,n-dmpea side to compare — that is a limit of the record, not a statement that N,n-dmpea has no side effects.

How to take them

Some Sorafenib Products Have a Food Rule — N,n-dmpea Should Not Break It

At least one FDA label for a product containing Sorafenib says to take it on an empty stomach. Most supplements — N,n-dmpea included — are taken with a meal, so the easy mistake is swallowing both together at breakfast. Where that rule applies, keep Sorafenib on its own and move N,n-dmpea to a meal later in the day.

This may not be true of your version. Food instructions belong to the product, not the ingredient: two Sorafenib products can carry different directions, and extended-release forms often differ from immediate-release ones. The label we read is quoted below — check the directions on your own box or bottle, or ask your pharmacist, for how to take the exact product you were given.

2 DOSAGE AND ADMINISTRATION The recommended dosage is 400 mg orally twice daily without food.

From the Dosage and Administration section of the FDA label we read for Sorafenib — where that label names a specific product, the instruction is that product's. Read the label on DailyMed ›

A food rule is not an interaction — it is about how much of the medicine you absorb. The directions that came with your own product, and your pharmacist, outrank anything on this page.

Everything else you take

See Every Supplement That Interacts With Sorafenib

This page covers N,n-dmpea only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Sorafenib page lists 285 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Danshen (major), Grapefruit (major), Piracetam (major) and St. John's Wort (major).

By severity: 5 major · 241 moderate · 39 minor.

From our pharmacist’s overview on the Sorafenib page

“If you're on sorafenib (Nexavar) for cancer, be genuinely careful here, and learn the five major-rated entries first. Most of the 285 ingredients listed either have blood-thinning effects that stack onto sorafenib's bleeding risk (more than 200 do) or affect CYP3A4, the liver enzyme that clears the drug, pushing its level too high or t…”

Reviewed by 2 · Jul 18, 2026

Open the Sorafenib interaction page

How much people look this up

Where N,n-dmpea and Sorafenib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement N,n-dmpea
Steady interest

#1,194 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Sorafenib
Steady interest

#1,809 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every N,n-dmpea reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The N,n-dmpea and Sorafenib records this page draws on were last updated June 22, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About N,n-dmpea

What is N,n-dmpea?

  • Mood or energy support
  • Pre-workout or stimulant effect
  • Cognitive or focus support

N,N-DMPEA (N,N-dimethylphenethylamine) is a synthetic relative of phenethylamine sometimes marketed in stimulant or pre-workout supplements. There is very little reliable human research on its effects or safety, and it is not a well-established dietary ingredient, so it should be approached with real caution.

Powder, capsules, research chemical

An interaction check asks whether these two react with each other — it does not ask whether N,n-dmpea is a good idea for someone in your situation. Here is what our N,n-dmpea record says about it on its own.

N,n-dmpea: dosing

There is no established or standardized safe dose of N,N-DMPEA. Because it has not been properly studied in humans, no reliable dosing guidance exists.If a product contains it, follow the product label, but understand that label amounts may not be accurate or safe.

From our N,n-dmpea monograph — the full record covers uses, side effects and every documented interaction.

Read the full N,n-dmpea monograph & all interactions
Medication

About Sorafenib

What Is Sorafenib Used For?

Brand name: Nexavar

Sorafenib tablets are approved to treat three types of cancer. The first is unresectable hepatocellular carcinoma (HCC) — liver cancer that cannot be removed with surgery. The second is advanced renal cell carcinoma (RCC) — kidney cancer that has spread or progressed. Both the brand Nexavar and generic sorafenib tablets are approved for these two uses.

The third use is for locally recurrent or metastatic, progressive differentiated thyroid carcinoma (DTC) — thyroid cancer that has spread or worsened and no longer responds to radioactive iodine treatment. Nexavar and sorafenib tablets are both approved for this use as well.

See full Sorafenib drug information
Keep checking

Other Drugs & N,n-dmpea

Browse every other medication we’ve checked against N,n-dmpea — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
193Moderate
0Minor
2,636No known interaction
Moderate

193 interactions

Showing 60 of 193 moderate interactions — see all 193 on the N,n-dmpea page.

No interaction 2,636 drugs checked — show the list
Evidence & sources

N,n-dmpea References

The 2 references that drive our N,n-dmpea monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Liu Y, Santillo MF. Cytochrome P450 2D6 and 3A4 enzyme inhibition by amine stimulants in dietary supplements. Drug Test Anal. 2016;8(3-4):307-10. PubMed
  2. Schoenwald RD, Vidvauns S, Wurster DE, Barfknecht CF. Tear film stability of protein extracts from dry eye patients administered a sigma agonist. J Ocul Pharmacol Ther 1997;13(2):151-61. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking N,n-dmpea and Sorafenib Together: Common Questions

Is it safe to take N,n-dmpea with Sorafenib?
We do not list a known interaction between N,n-dmpea and Sorafenib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Should I take N,n-dmpea and Sorafenib at the same time of day?
At least one FDA label for a product containing Sorafenib says to take it on an empty stomach, and supplements are usually taken with a meal — so taking them together at breakfast is the easy mistake. Where that applies, keep Sorafenib on its own and move N,n-dmpea to a meal later in the day. Food instructions belong to the product rather than the ingredient, so check the directions on your own box. This is about absorption, not an interaction.
How was the N,n-dmpea and Sorafenib combination checked?
Interactions in our licensed database are recorded against drug classes. Sorafenib is filed under 4 classifications, and N,n-dmpea has documented interactions with 1 drug class — none of Sorafenib's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does N,n-dmpea interact with any other medications?
Yes. N,n-dmpea has 193 documented drug interactions in our database — Sorafenib is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Sorafenib interact with any supplements?
Yes. Sorafenib has documented interactions with 285 supplements in our database — N,n-dmpea is not one of them. The Sorafenib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Sorafenib and N,n-dmpea?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.